🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of the current study is to investigate the efficacy, safety a...
Status
Completed
Location
1218.20.10033 Boehringer Ingelheim Investigational Site
Start Date
2008-02
Trial ID
NCT00622284
The objective of the study is to test the efficacy, safety and tolerability...
Status
Completed
Location
1218.6.3302A Boehringer Ingelheim Investigational Site
Start Date
2006-04
Trial ID
NCT00309608
Treatments Being Tested
The objective of the current study is to investigate the efficacy, safety a...
Status
Completed
Location
1218.18.54001 Boehringer Ingelheim Investigational Site
Start Date
2008-02
Trial ID
NCT00602472
Treatments Being Tested
The objective of this study is to investigate the effect of BI 1356 on 24-h...
Status
Completed
Location
1218.37.49003 Boehringer Ingelheim Investigational Site
Start Date
2008-07
Trial ID
NCT00716092
Assessment of the effect of BI 1356 or Placebo on prolongation of the QT in...
Status
Completed
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT02183467
Treatments Being Tested
to determine safety, efficacy and tolerability of BI 1356 versus placebo...
Status
Completed
Location
1218.43.10027 Boehringer Ingelheim Investigational Site
Start Date
2008-12
Trial ID
NCT00800683
Efficacy and safety of BI 1356 compared to placebo in patients with type 2 ...
Status
Completed
Location
1218.35.10002 Boehringer Ingelheim Investigational Site
Start Date
2008-12
Trial ID
NCT00819091
The objective of the current study is to investigate the efficacy, safety a...
Status
Completed
Location
1218.17.10003 Boehringer Ingelheim Investigational Site
Start Date
2008-01
Trial ID
NCT00601250
Treatments Being Tested
The objective of the current study was to investigate safety, tolerability,...
Status
Completed
Location
Multiple Locations
Start Date
2004-10
Trial ID
NCT02173665
Treatments Being Tested
The objective of the current study is to investigate the safety and tolerab...
Status
Completed
Location
1218.40.10003 Boehringer Ingelheim Investigational Site
Start Date
2008-08
Trial ID
NCT00736099
Treatments Being Tested